Table 4.
Critical analysis of amide-based repositionable drugs.
| Entry | Structures | LogP 1 | TPSA 2 (Å) |
M (g/mol) | Druglikeliness 3 (Alert) |
BBB Permeant 4 | GI 5 Absorption |
|---|---|---|---|---|---|---|---|
| 1 |
 Ciclopirox |
2.38 | 42.23 | 207.27 | MW < 250 | Yes | High |
| 2 |
 Ebselen |
1.75 | 22.0 | 274.18 | No alert | Yes | High |
| 3 |
 Rolipram |
2.44 | 47.56 | 275.34 | No alert | Yes | High |
| 4 |
 Fipexide |
2.82 | 51.24 | 388.84 | MW > 350 | Yes | High |
| 5 |
 Taurolidine |
−1.53 | 115.58 | 284.36 | 0 alert | No | Low |
1. LogP = octanol/water partition coefficient calculated by SwissADME; 2 TPSA = topology polar surface area by SwissADME; 3 Druglikliness = criteria which should be problematic for drug development according to SwissADME; 4 BBB permeant: blood brain barrier permeant as predicted by SwissADME; 5 gastro-intestinal permeation ability as predicted by SwissADME.